4-[8-[2-[2-chloro-4-(trifluoromethyl)anilino]-2-oxoethyl]-1'-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2-oxospiro[5-oxa-1,8,10,12-tetrazatricyclo[7.3.0.03,7]dodeca-3(7),9,11-triene-4,4'-piperidine]-11-yl]-N-methyl-3,6-dihydro-2H-pyridine-1-carboxamide
C33H32ClF3N10O6 — CID 177162538
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[8-[2-[2-chloro-4-(trifluoromethyl)anilino]-2-oxoethyl]-1'-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2-oxospiro[5-oxa-1,8,10,12-tetrazatricyclo[7.3.0.03,7]dodeca-3(7),9,11-triene-4,4'-piperidine]-11-yl]-N-methyl-3,6-dihydro-2H-pyridine-1-carboxamide
4-[8-[2-[2-chloro-4-(trifluoromethyl)anilino]-2-oxoethyl]-1'-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2-oxospiro[5-oxa-1,8,10,12-tetrazatricyclo[7.3.0.03,7]dodeca-3(7),9,11-triene-4,4'-piperidine]-11-yl]-N-methyl-3,6-dihydro-2H-pyridine-1-carboxamide (PubChem CID 177162538) has the molecular formula C33H32ClF3N10O6 and a molecular weight of 757.13 g/mol. Its IUPAC name is 4-[8-[2-[2-chloro-4-(trifluoromethyl)anilino]-2-oxoethyl]-1'-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2-oxospiro[5-oxa-1,8,10,12-tetrazatricyclo[7.3.0.03,7]dodeca-3(7),9,11-triene-4,4'-piperidine]-11-yl]-N-methyl-3,6-dihydro-2H-pyridine-1-carboxamide.
Molecular Properties
| Compound Name | 4-[8-[2-[2-chloro-4-(trifluoromethyl)anilino]-2-oxoethyl]-1'-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2-oxospiro[5-oxa-1,8,10,12-tetrazatricyclo[7.3.0.03,7]dodeca-3(7),9,11-triene-4,4'-piperidine]-11-yl]-N-methyl-3,6-dihydro-2H-pyridine-1-carboxamide |
|---|---|
| PubChem CID | 177162538 |
| Molecular Formula | C33H32ClF3N10O6 |
| Molecular Weight | 757.13 g/mol |
| Exact Mass | 756.21 |
| IUPAC Name | 4-[8-[2-[2-chloro-4-(trifluoromethyl)anilino]-2-oxoethyl]-1'-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2-oxospiro[5-oxa-1,8,10,12-tetrazatricyclo[7.3.0.03,7]dodeca-3(7),9,11-triene-4,4'-piperidine]-11-yl]-N-methyl-3,6-dihydro-2H-pyridine-1-carboxamide |
| SMILES | CNC(=O)N1CC=C(c2nc3n(CC(=O)Nc4ccc(C(F)(F)F)cc4Cl)c4c(c(=O)n3n2)C2(CCN(C(=O)c3ncnc(C)c3O)CC2)OC4)CC1 |
| InChI | InChI=1S/C33H32ClF3N10O6/c1-17-26(49)25(40-16-39-17)29(51)44-11-7-32(8-12-44)24-22(15-53-32)46(14-23(48)41-21-4-3-19(13-20(21)34)33(35,36)37)30-42-27(43-47(30)28(24)50)18-5-9-45(10-6-18)31(52)38-2/h3-5,13,16,49H,6-12,14-15H2,1-2H3,(H,38,52)(H,41,48) |
| InChIKey | XJZDWQRFMFLILQ-UHFFFAOYSA-N |
| XLogP | 3.10 |
| TPSA | 189.18 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 757.13 |
| LogP ≤ 5 | 3.10 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177162538 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.